AbCellera Biologics Inc. - COM (ABCL)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
105M
Holdings value Q3 2024
$272M
Value change Q3 2024
-$17.9M
Grand Portfolio weight change Q3 2024
0%
Number of holders
138
Number of buys Q3 2024
70
Number of sells Q3 2024
-59
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 105M $272M -$17.9M $2.60 138
2024 Q2 114M $338M -$10.3M $2.96 146
2024 Q1 120M $542M +$1.2M $4.53 151
2023 Q4 119M $681M +$1.51M $5.71 140
2023 Q3 119M $547M -$36.6M $4.60 135
2023 Q2 125M $809M -$42.7M $6.46 165
2023 Q1 130M $980M +$9.96M $7.54 180
2022 Q4 128M $1.3B +$62.6M $10.13 195
2022 Q3 121M $1.2B +$19.8M $9.89 182
2022 Q2 118M $1.26B +$77.6M $10.65 159
2022 Q1 113M $1.1B -$3.56M $9.75 125
2021 Q4 113M $1.6B +$96.1M $14.30 119
2021 Q3 96.9M $1.94B +$137M $20.04 114
2021 Q2 89.7M $1.97B +$163M $22.00 111
2021 Q1 70.5M $2.4B +$64.1M $33.96 80
2020 Q4 68.1M $2.74B +$2.59B $40.24 58